amikacin has been researched along with lactic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Kau, YC; Liaw, CW; Liu, SJ; Peng, YJ | 1 |
Kau, YC; Liu, KS; Liu, SJ; Peng, YJ; Wen, CW | 1 |
Abdi-Ali, A; Gamazo, C; Irache, JM; Sabaeifard, P; Soudi, MR | 2 |
6 other study(ies) available for amikacin and lactic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
In vitro elution of vancomycin/amikacin/steroid from solvent-free biodegradable scleral plugs.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Drug Stability; Drug Therapy, Combination; Endophthalmitis; Escherichia coli; Glucocorticoids; Lactic Acid; Microbial Sensitivity Tests; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sclera; Staphylococcus aureus; Vancomycin | 2009 |
Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biocompatible Materials; Dexamethasone; Drug Carriers; Drug Delivery Systems; Endophthalmitis; Lactic Acid; Materials Testing; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Rabbits; Sclera; Solvents; Vancomycin | 2010 |
Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Drug Carriers; Drug Liberation; Lactic Acid; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; RAW 264.7 Cells | 2016 |
Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Drug Resistance, Multiple, Bacterial; Lactic Acid; Macrophages; Mice; Microbial Sensitivity Tests; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections; RAW 264.7 Cells | 2017 |